Journal
JOURNAL OF IMMUNOLOGY
Volume 174, Issue 3, Pages 1557-1565Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.174.3.1557
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL66415, HL64344] Funding Source: Medline
- NIA NIH HHS [AG021191] Funding Source: Medline
Ask authors/readers for more resources
Activated neutrophils use myeloperoxidase (MPO) to generate an array of potent toxic oxidants. In the current studies we used genetically altered mice deficient in MPO to investigate the role of the enzyme in host defense against the Gram-negative bacterium Klebsiella pneunioniae, an important human pathogen. For comparison. we used mice deficient in the antimicrobial molecule, neutrophil elastase (NE). When challenged i.p., mice deficient in either MPO or NE were markedly more susceptible to bacterial infection and death. In vitro studies suggested that MPO impairs the morphology of bacteria in a distinctive way. or importance our in vitro studies found that MPO mediated oxidative inactivation of NE. an enzyme that has been widely implicated in the pathogenesis of various tissue-destructive diseases. This pathway of oxidative inactivation may be physiologically relevant. bemuse activated neutrophils isolated front MPO-deficient mice exhibited increased elastase activity. Our observations provide strong evidence that MPO, like NE, is a key player in the killing of K. pneunioniae bacteria. They also suggest that MPO may modulate NE to protect the host front the tissue-degrading activity of this proteinase.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available